← Evidence map

ArticlemAbs2025

Analytical development and application of a targeted liquid chromatography-tandem mass spectrometry assay for chimeric aducanumab.

Emma H Doud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40693538